Your Catalyst To a Lucrative Business Respiratory Syncytial Virus (RSV) Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research " The global RSV diagnostics market was estimated at USD 625 million in 2015. This market is anticipated to propagate at a high CAGR of over 10% from 2016 to 2024." The worldwide Respiratory Syncytial Virus Diagnostics Market is poised to grow at a CAGR exceeding 10% over the forecast period (2016 to 2024). It stood at USD 625 million in 2015. High prevalence of neonatal infections & viral diseases and the need for early RSV detection mechanisms for infants are key drivers of this industry. Respiratory syncytial virus harms the respiratory tract, the immune system, the heart, and lungs; thus leading to serious illnesses. It mainly affects infants in the age group of 0 to 11 months. However, there are instances of people above the age of 60 years being afflicted by this virus. This is essentially because of weak immunity. Some patients may even need hospitalization. Clinical symptoms of the RSV infection can seldom be distinguished from the symptoms of other respiratory disorders. Hence, there is a pressing need to develop precise & accurate diagnostic solutions for such a disease. The global RSV Diagnostics market is categorized on the basis of products, end use, and regions. On the basis of products, the segments are DFA (direct fluorescence antibody) method, RADTs (rapid antigen diagnostic tests), flow cytometry, molecular diagnostics, gel microdroplets, diagnostic imaging, chromatographic immunoassay, and others. Due to high accuracy & precision, the molecular diagnostics segment may lead the overall industry during the forecast period. Browse Details of Report @ https://www.hexaresearch.com/research-report/respiratory-syncytial-virusdiagnostics-market Follow Us: Your Catalyst To a Lucrative Business Based on end uses, the industry is divided into clinics, hospitals, homecare, and laboratory. Hospitals held the largest share in 2015. It is expected that this segment will continue dominating the RSV Diagnostics market because of high hospitalization rate of RSV infected patients. “Homecare” too may expand significantly in the forthcoming years because of high demand for perinatal & in-house testing. Surging popularity of homecare services owes to high governmental investments in training programs for the same. Geographically, the global Respiratory Syncytial Virus Diagnostics Market is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. With a market share surpassing 45%, North America led the industry in 2015. This region is propelled by high incidence of respiratory tract infections. Governmental initiatives, such as PAHO (Pan American Health Organization) may significantly contribute to market demand over the next couple of years. As per this initiative, it is absolutely necessary to rule out the possibilities of infections & metabolic defects in newborns. Asia Pacific may register a high growth rate from 2016 to 2024. High incidence of infectious diseases fueled by moderate to poor living conditions propels this regional market. Other factors that may drive this region are improved healthcare infrastructure, high R&D funding, favorable government mandates, and steady technological advancements. Prominent vendors in the worldwide industry are Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics; Abbott Laboratories; Roche Diagnostics; and Quest Diagnostics. In 2016, Luminex Corporation, a U.S. based biotechnology company received U.S. FDA (Food and Drug Administration) approval for its ARIES Flu A/B & RSV Assay. This device helps detect three main respiratory pathogens namely, RSV and influenza A & B viruses. It delivers results within two hours. Furthermore, it is equipped with a panel customization feature that gives it the ability to report the required results only. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinicaldiagnostics-industry Follow Us: Your Catalyst To a Lucrative Business Table of Content of Respiratory Syncytial Virus (RSV) Diagnostics Market Table of Contents Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions 1.3. List of Data Sources Chapter 2. Executive Summary 2.1. Respiratory Syncytial Virus Diagnostics Market– Industry Snapshot and Key Buying Criteria, 2014 Chapter 3. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Industry Outlook 3.1. Respiratory Syncytial Virus Diagnostics Market: Segmentation 3.2. Respiratory Syncytial Virus Diagnostics Market: Size And Growth Prospects 3.3. Respiratory Syncytial Virus Diagnostics Market: Market Dynamics 3.3.1. Market Driver Analysis 3.3.2. Market Restraint Analysis 3.4. Key Opportunities Prioritized 3.5. Industry Analysis - Porter's 3.6. Respiratory Syncytial Virus Diagnostics Company Market Share, 2016 3.7. Respiratory Syncytial Virus Diagnostics Market: PESTEL Analysis, 2016 3.8. Respiratory Syncytial Virus Diagnostics Technology Overview Chapter 4. Global Respiratory Syncytial Virus Diagnostics (RSV) Market Product Outlook 4.1. Respiratory Syncytial Virus Diagnostics Market Share, By Product, 2016 & 2024 4.2. Direct Fluorescence Antibody (DFA) Method 4.2.1. Direct Fluorescence Antibody (DFA) Method Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.3. Rapid Antigen Diagnostic Test(RADTs) 4.3.1. Rapid Antigen Diagnostic Test (RADTs) Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.4. Molecular Diagnostics 4.4.1. Molecular Diagnostics Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.5. Chromatographic Immunoassay 4.5.1. Chromatographic Immunoassay Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.6. Diagnostic Imaging 4.6.1. Diagnostic Imaging Market Estimates And Forecasts, 2016 - 2024 (USD Million) Follow Us: Your Catalyst To a Lucrative Business 4.7. Gel Microdroplets 4.7.1. Gel Microdroplets Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.8. Flow Cytometry 4.8.1. Flow Cytometry Market Estimates And Forecasts, 2016 - 2024 (USD Million) 4.9. Others 4.9.1. Other Market Estimates And Forecasts, 2016 - 2024 (USD Million) Chapter 5. Global Respiratory Syncytial Virus Diagnostics (RSV) End-use Outlook 5.1. Respiratory Syncytial Virus Diagnostics Market Share, By End-use, 2016 & 2024 5.2. Hospitals 5.2.1. Hospitals Based RSV Diagnostics Market Estimates And Forecasts, 2016 - 2024 (USD Million) 5.3. Laboratory 5.3.1. Laboratory Based RSV Diagnostics Market Estimates And Forecasts, 2016 - 2024 (USD Million) 5.4. Clinics 5.4.1. Clinics Based RSV Diagnostics Market Estimates And Forecasts, 2016 - 2024 (USD Million) 5.5. Homecare 5.5.1. Homecare Based RSV Diagnostics Market Estimates And Forecasts, 2016 - 2024 (USD Million) Chapter 6. Global Respiratory Syncytial Virus Diagnostics Market Regional Outlook 6.1. Respiratory Syncytial Virus Diagnostics Market Share, By Region, 2016 & 2024 6.2. North America 6.2.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product, (USD Million), 2016 - 2024 6.2.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use, (USD Million), 2016 - 2024 6.2.2.1. U.S. Estimates and Forecasts 6.2.2.2. Canada Estimates and Forecasts 6.3. Europe 6.3.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2016 - 2024 6.3.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End -use (USD Million), 2016 - 2024 6.3.2.1. UK Estimates and Forecasts 6.3.2.2. Germany Estimates and Forecasts 6.3.2.3. France Estimates and Forecasts 6.3.2.4. Spain Estimates and Forecasts Follow Us: Your Catalyst To a Lucrative Business 6.3.2.5. Italy Estimates and Forecasts 6.4. Asia Pacific 6.4.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2016 - 2024 6.4.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use (USD Million), 2016 - 2024 6.4.2.1. Japan Estimates and Forecasts 6.4.2.2. China Estimates and Forecasts 6.4.2.3. India Estimates and Forecasts 6.5. Latin America 6.5.1. Respiratory Syncytial Virus Diagnostics Estimates And Forecasts, By Product (USD Million), 2016 - 2024 6.5.2. Respiratory Syncytial Virus Diagnostics Estimates And Forecasts, By End -use (USD Million), 2016 - 2024 6.5.2.1. Brazil Estimates and Forecasts 6.5.2.2. Mexico Estimates and Forecasts 6.5.2.3. Argentina Estimates and Forecasts 6.5.2.4. Peru Estimates and Forecasts 6.6. MEA 6.6.1. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By Product (USD Million), 2016 - 2024 6.6.2. Respiratory Syncytial Virus Diagnostics Market Estimates And Forecasts, By End-use (USD Million), 2016 - 2024 6.6.2.1. South Africa Estimates and Forecasts 6.6.2.2. Saudi Arabia Estimates and Forecasts Chapter 7. Competitive Landscape 7.1. Becton Dickinson and Company 7.1.1. Company Overview 7.1.2. Financial Performance 7.1.3. Product Benchmarking 7.1.4. Strategic Initiatives 7.2. Novartis Diagnostics 7.2.1. Company Overview 7.2.2. Financial Performance 7.2.3. Product Benchmarking 7.2.4. Strategic Initiatives 7.3. Abbott Laboratories Follow Us: Your Catalyst To a Lucrative Business 7.3.1. Company Overview 7.3.2. Financial Performance 7.3.3. Product Benchmarking 7.3.4. Strategic Initiatives 7.4. Ortho Clinical Diagnostics 7.4.1. Company Overview 7.4.2. Financial Performance 7.4.3. Product Benchmarking 7.4.4. Strategic Initiatives 7.5. Thermo Fisher Scientific Inc. 7.5.1. Company Overview 7.5.2. Financial Performance 7.5.3. Product Benchmarking 7.5.4. Strategic Initiatives 7.6. Bio-Rad Laboratories Inc. 7.6.1. Company Overview 7.6.2. Financial Performance 7.6.3. Product Benchmarking 7.6.4. Strategic Initiatives 7.7. Hoffmann La Roche Ltd. 7.7.1. Company Overview 7.7.2. Financial Performance 7.7.3. Product Benchmarking 7.7.4. Strategic Initiatives 7.8. BioMerieux 7.8.1. Company Overview 7.8.2. Financial Performance 7.8.3. Product Benchmarking 7.8.4. Strategic Initiatives 7.9. DiaSorin SPA 7.9.1. Company Overview 7.9.2. Financial Performance 7.9.3. Product Benchmarking 7.9.4. Strategic Initiatives 7.10. EMD Millipore 7.10.1. Company Overview Follow Us: Your Catalyst To a Lucrative Business 7.10.2. Financial Performance 7.10.3. Product Benchmarking 7.10.4. Strategic Initiatives 7.11. Quidel Corporation 7.11.1. Company Overview 7.11.2. Financial Performance 7.11.3. Product Benchmarking 7.11.4. Strategic Initiatives 7.12. Alere Inc. 7.12.1. Company Overview 7.12.2. Financial Performance 7.12.3. Product Benchmarking 7.12.4. Strategic Initiatives 7.13. Coris BioConcept 7.13.1. Company Overview 7.13.2. Financial Performance 7.13.3. Product Benchmarking 7.13.4. Strategic Initiatives 7.14. Fast-track Diagnostics 7.14.1. Company Overview 7.14.2. Financial Performance 7.14.3. Product Benchmarking 7.14.4. Strategic Initiatives 7.15. Quest Diagnostics 7.15.1. Company Overview 7.15.2. Financial Performance 7.15.3. Product Benchmarking 7.15.4. Strategic Initiatives Follow Us: Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit our Blog: hexaresearch1.blogspot.com Follow Us:
The global Respiratory Syncytial Virus (RSV) Diagnostics market was estimated at USD 625 million in 2015. This market is anticipated to propagate at a high CAGR of over 10% from 2016 to 2024.
© Copyright 2024 Paperzz
